releases: https://www.lee.senate.gov/2024/2/senators-alarmed-by-fda-s-chief-scientist-s-perspectives-on-promotions
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://www.lee.senate.gov/2024/2/senators-alarmed-by-fda-s-chief-scientist-s-perspectives-on-promotions | Senators Alarmed by FDA's Chief Scientist's Perspectives on Promotions | 2024-02-08 | 2024 | 2024-02 | Republican | Senate | UT | Mike Lee | L000577 | www.lee.senate.gov | mikelee | https://www.lee.senate.gov/press-releases | scraper | WASHINGTON – Senator Mike Lee (R-UT), joined by Senators Eric Schmitt (R-MO) and Mike Braun (R-IN), raised concerns to FDA Commissioner Robert Califf about the expressed views of Dr. Namandje Bumpus, the agency's Chief Scientist. The letter urges Commissioner Califf to consider how Dr. Bumpus's potential promotion to Principal Deputy Commissioner could influence the FDA's hiring and promotion practices and questions whether her perspective aligns with the FDA's mission to protect public health. For the full letter, click HERE. | 1 | 2026-03-30T01:40:41Z | 2026-04-07T20:21:00Z |